US Stock MarketDetailed Quotes
SNDX Syndax Pharmaceuticals
- 21.350
- +1.660+8.43%
Close Nov 6 16:00 ET
- 21.350
- 0.0000.00%
Post 20:01 ET
1.82BMarket Cap-5865P/E (TTM)
22.260High20.340Low3.84MVolume21.600Open19.690Pre Close80.89MTurnover4.52%Turnover RatioLossP/E (Static)85.36MShares25.34052wk High4.97P/B1.82BFloat Cap13.14052wk Low--Dividend TTM85.02MShs Float29.860Historical High--Div YieldTTM9.75%Amplitude3.390Historical Low21.067Avg Price1Lot Size
Syndax Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.5M | 3.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --12.5M | --3.5M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 81.13%102.08M | 56.44%77.72M | 72.80%79.51M | 51.53%229.95M | 85.34%77.91M | 60.37%56.36M | 31.69%49.68M | 24.84%46.02M | 33.72%151.76M | 36.35%42.03M |
| Selling and administrative expenses | 80.14%31.11M | 94.86%29.06M | 92.48%23.02M | 101.22%66.92M | 123.50%22.78M | 109.56%17.27M | 86.66%14.91M | 74.97%11.96M | 31.76%33.26M | 47.13%10.19M |
| -General and administrative expense | 80.14%31.11M | 94.86%29.06M | 92.48%23.02M | ---- | ---- | 109.56%17.27M | 86.66%14.91M | 74.97%11.96M | ---- | ---- |
| Research and development costs | 81.57%70.97M | 39.96%48.66M | 65.89%56.49M | 37.58%163.03M | 73.13%55.13M | 45.30%39.09M | 16.92%34.76M | 13.43%34.05M | 34.28%118.5M | 33.23%31.84M |
| Operating profit | -58.95%-89.58M | -49.39%-74.22M | -72.80%-79.51M | -51.53%-229.95M | -85.34%-77.91M | -60.37%-56.36M | -31.69%-49.68M | -24.84%-46.02M | -678.78%-151.76M | -143.90%-42.03M |
| Net non-operating interest income expense | 2.73%5.42M | 21.00%6.24M | 42.99%7.2M | 666.18%20.96M | 86.32%5.49M | 15,884.85%5.28M | 2,717.49%5.16M | 1,279.39%5.04M | 282.82%2.74M | 2,905.10%2.95M |
| Non-operating interest income | 1.81%5.44M | 21.06%6.28M | 42.95%7.26M | 260.41%21.16M | 85.74%5.55M | 200.11%5.35M | 491.23%5.19M | 2,166.07%5.08M | 1,357.07%5.87M | 3,183.52%2.99M |
| Non-operating interest expense | -67.14%23K | 28.57%45K | 37.50%55K | -93.37%208K | 46.51%63K | -96.00%70K | -94.96%35K | -93.86%40K | 65.19%3.14M | 714.29%43K |
| Other net income (expense) | 148.48%32K | 7.53%-86K | 40.82%-87K | -14.24%-361K | 48.11%-55K | 77.63%-66K | -200.00%-93K | -226.72%-147K | -256.44%-316K | -130.20%-106K |
| Other non- operating income (expenses) | 148.48%32K | 7.53%-86K | 40.82%-87K | -14.24%-361K | 48.11%-55K | 77.63%-66K | -200.00%-93K | -226.72%-147K | -256.44%-316K | -130.20%-106K |
| Income before tax | -64.48%-84.13M | -52.56%-68.06M | -76.04%-72.4M | -40.19%-209.36M | -84.91%-72.47M | -44.47%-51.15M | -18.75%-44.62M | -10.65%-41.13M | -699.13%-149.34M | -140.74%-39.19M |
| Income tax | ||||||||||
| Net income | -64.48%-84.13M | -52.56%-68.06M | -76.04%-72.4M | -40.19%-209.36M | -84.91%-72.47M | -44.47%-51.15M | -18.75%-44.62M | -10.65%-41.13M | -699.13%-149.34M | -140.74%-39.19M |
| Net income continuous Operations | -64.48%-84.13M | -52.56%-68.06M | -76.04%-72.4M | -40.19%-209.36M | -84.91%-72.47M | -44.47%-51.15M | -18.75%-44.62M | -10.65%-41.13M | -699.13%-149.34M | -140.74%-39.19M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -64.48%-84.13M | -52.56%-68.06M | -76.04%-72.4M | -40.19%-209.36M | -84.91%-72.47M | -44.47%-51.15M | -18.75%-44.62M | -10.65%-41.13M | -699.13%-149.34M | -140.74%-39.19M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -64.48%-84.13M | -52.56%-68.06M | -76.04%-72.4M | -40.19%-209.36M | -84.91%-72.47M | -44.47%-51.15M | -18.75%-44.62M | -10.65%-41.13M | -699.13%-149.34M | -140.74%-39.19M |
| Basic earnings per share | -34.25%-0.98 | -25.00%-0.8 | -44.07%-0.85 | -21.14%-2.98 | -61.29%-1 | -25.86%-0.73 | -3.23%-0.64 | 6.35%-0.59 | -612.50%-2.46 | -134.25%-0.62 |
| Diluted earnings per share | -34.25%-0.98 | -25.00%-0.8 | -44.07%-0.85 | -21.14%-2.98 | -61.29%-1 | -25.86%-0.73 | -3.23%-0.64 | 6.35%-0.59 | -634.78%-2.46 | -134.25%-0.62 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data